Arcturus Therapeutics Ltd. Net Income
Arcturus Therapeutics Ltd. reported Net Income of -$6.88 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2019-05-13
- Arcturus Therapeutics Ltd. net income (loss) attributable to parent for the quarter ending 2019-03-31 was -$6.88M.
- Arcturus Therapeutics Ltd. net income (loss) attributable to parent for the quarter ending 2018-12-31 was -$1.01M.
- Arcturus Therapeutics Ltd. net income (loss) attributable to parent for the quarter ending 2018-09-30 was -$4.25M.
- Arcturus Therapeutics Ltd. net income (loss) attributable to parent for the quarter ending 2018-06-30 was -$9.95M.
- Arcturus Therapeutics Ltd. net income (loss) attributable to parent for fiscal 2018 was -$21.79M.
- Arcturus Therapeutics Ltd. net income (loss) attributable to parent for fiscal 2017 was -$10.90M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 11 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed | Net Income (Loss) Attributable to Parent 71 month |
|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$6.88M 10-Q · filed 2019-05-13 | -$7.89M derived: sum of 2 quarters · filed 2019-05-13 | -$12.15M derived: sum of 3 quarters · filed 2019-05-13 | -$22.10M derived: sum of 4 quarters · filed 2019-05-13 | |||
| 2018-12-31 | -$1.01M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | -$5.26M derived: sum of 2 quarters · filed 2019-03-18 | -$15.21M derived: sum of 3 quarters · filed 2019-03-18 | -$21.79M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | -$4.25M 6-K · filed 2018-11-07 | -$14.20M derived: sum of 2 quarters · filed 2018-11-07 | -$20.77M 6-K · filed 2018-11-07 | -$26.05M derived: sum of 4 quarters · filed 2019-05-13 | |||
| 2018-06-30 | -$9.95M 6-K · filed 2018-11-07 | -$16.52M 6-K · filed 2018-09-28 | -$21.80M derived: sum of 3 quarters · filed 2019-05-13 | -$24.98M derived: sum of 4 quarters · filed 2019-05-13 | |||
| 2018-03-31 | -$6.57M 10-Q · filed 2019-05-13 | -$11.85M derived: sum of 2 quarters · filed 2019-05-13 | -$15.03M derived: sum of 3 quarters · filed 2019-05-13 | -$16.13M derived: sum of 4 quarters · filed 2019-05-13 | |||
| 2017-12-31 | -$5.28M 6-K · filed 2018-11-07 | -$8.46M derived: sum of 2 quarters · filed 2018-11-07 | -$9.56M derived: sum of 3 quarters · filed 2018-11-07 | -$10.90M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | -$3.18M 6-K · filed 2018-11-07 | -$4.28M derived: sum of 2 quarters · filed 2018-11-07 | -$5.62M 6-K · filed 2018-11-07 | ||||
| 2017-06-30 | -$1.10M 6-K · filed 2018-11-07 | -$2.44M 6-K · filed 2018-09-28 | |||||
| 2017-03-31 | -$1.35M 6-K · filed 2018-11-07 | ||||||
| 2016-12-31 | -$1.57M 20-F · filed 2018-05-14 | -$24.60M 20-F · filed 2017-04-28 | |||||
| 2015-12-31 | -$1.90M 20-F · filed 2018-05-14 | -$19.45M 20-F · filed 2016-03-04 | |||||
| 2014-12-31 | -$32.83M 20-F · filed 2017-04-28 | ||||||
| 2013-12-31 | -$10.55M 20-F · filed 2016-03-04 | -$18.55M 20-F · filed 2014-03-28 | |||||
| 2012-12-31 | -$1.58M 20-F · filed 2015-02-27 | ||||||
| 2011-12-31 | -$3.93M 20-F · filed 2014-03-28 | ||||||
| 2010-12-31 | -$1.22M 20-F · filed 2014-03-28 | ||||||
| 2009-12-31 | -$608.00K 20-F · filed 2014-03-28 | ||||||
| 2008-12-31 | -$666.00K 20-F · filed 2014-03-28 |